speb/financial-data huggingface dataset:
VEON income_statement (quarterly, 2025-12-31) — Total Expenses: 822000000.00
VEON balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 7581000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 7581000000.00
VEON balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 6102000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 6102000000.00
VEON balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 4145000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 4145000000.00
VEON income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1439000000.00
VEON income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 321000000.00
VEON balance_sheet (annual, 2025-12-31) — Total Tax Payable: 217000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 217000000.00
VEON income_statement (annual, 2025-12-31) — Total Unusual Items: 200000000.00
VEON income_statement (quarterly, 2025-12-31) — Total Unusual Items: -138000000.00
VEON income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 200000000.00
VEON income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -138000000.00
VEON balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 130003933.00
VEON balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 130003933.00
VEON balance_sheet (annual, 2025-12-31) — Working Capital: -323000000.00
VEON balance_sheet (quarterly, 2025-12-31) — Working Capital: -323000000.00
VEON income_statement (annual, 2025-12-31) — Write Off: 35000000.00
VEON income_statement (quarterly, 2025-12-31) — Write Off: 29000000.00
VEON income_statement (quarterly, 2026-03-31) — +Operating Expense: 742000000.00
VEON income_statement (quarterly, 2026-03-31) — +Total Revenue: 1201000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1495000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 304000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 12753000000.00
VEON income_statement (quarterly, 2026-03-31) — Amortization: 59000000.00
VEON cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 59000000.00
VEON cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 59000000.00
VEON income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 59000000.00
VEON cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 2000000.00
VEON income_statement (quarterly, 2026-03-31) — Basic Average Shares: 69600000.00
VEON income_statement (quarterly, 2026-03-31) — Basic EPS: 1.50
VEON cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1732000000.00
VEON cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -264000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1751000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2183000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 1022000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Cash Financial: 729000000.00
VEON cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -87000000.00
VEON cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -295000000.00
VEON cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 396000000.00
VEON cash_flow (quarterly, 2026-03-31) — Change In Inventory: 3000000.00
VEON cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 17000000.00
VEON cash_flow (quarterly, 2026-03-31) — Change In Payable: 39000000.00
VEON cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 39000000.00
VEON cash_flow (quarterly, 2026-03-31) — Change In Receivables: -40000000.00
VEON cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 19000000.00
VEON cash_flow (quarterly, 2026-03-31) — Changes In Cash: 14000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Common Stock: 2000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1468000000.00
VEON cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -28000000.00
VEON income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 151000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Current Assets: 3120000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1419000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3629000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Current Provisions: 76000000.00
VEON cash_flow (quarterly, 2026-03-31) — Depreciation: 150000000.00
VEON cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 209000000.00
VEON income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 209000000.00
VEON cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 209000000.00
VEON income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 209000000.00
VEON income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 150000000.00
VEON income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 71400000.00
VEON income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.50
VEON income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 99000000.00
VEON income_statement (quarterly, 2026-03-31) — EBIT: 333000000.00
VEON income_statement (quarterly, 2026-03-31) — EBITDA: 542000000.00
VEON cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 5000000.00
VEON cash_flow (quarterly, 2026-03-31) — End Cash Position: 1751000000.00
VEON cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -87000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: -6210000000.00
VEON cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 132000000.00
VEON income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 15000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -8388000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1894000000.00
VEON income_statement (quarterly, 2026-03-31) — Gross Profit: 1050000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 100000000.00
VEON income_statement (quarterly, 2026-03-31) — Interest Expense: 150000000.00
VEON income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 150000000.00
VEON income_statement (quarterly, 2026-03-31) — Interest Income: 18000000.00
VEON income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 18000000.00
VEON cash_flow (quarterly, 2026-03-31) — Interest Paid Cfo: -87000000.00
VEON cash_flow (quarterly, 2026-03-31) — Interest Received Cfo: 12000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Inventory: 29000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1468000000.00
VEON cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -295000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 108000000.00
VEON cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 146000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Loans Receivable: 345000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4004000000.00
VEON cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 146000000.00
VEON cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -225000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 41000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Minority Interest: 395000000.00
VEON income_statement (quarterly, 2026-03-31) — Minority Interests: -24000000.00
VEON cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -105000000.00
VEON cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -28000000.00
VEON cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -15000000.00
VEON income_statement (quarterly, 2026-03-31) — Net Income: 99000000.00
VEON income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 99000000.00
VEON income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 123000000.00
VEON income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 99000000.00
VEON income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 99000000.00
VEON cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 183000000.00
VEON income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 123000000.00
VEON cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -32000000.00
VEON income_statement (quarterly, 2026-03-31) — Net Interest Income: -132000000.00
VEON cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -79000000.00
VEON cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -79000000.00
VEON income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -132000000.00
VEON cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 20000000.00
VEON cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 40000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Net PPE: 3824000000.00
VEON cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -198000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -426000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 439000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 48000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 439000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 48000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Non Current Note Receivables: 42000000.00
VEON income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 529000000.00
VEON income_statement (quarterly, 2026-03-31) — Normalized Income: 90264000.00
VEON cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 396000000.00
VEON cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -15000000.00
VEON income_statement (quarterly, 2026-03-31) — Operating Income: 308000000.00
VEON income_statement (quarterly, 2026-03-31) — Operating Revenue: 1201000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1731034184.00
VEON cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 0.00
VEON balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 215000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 539000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -2178000000.00
VEON income_statement (quarterly, 2026-03-31) — Other Income Expense: 7000000.00
VEON cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 138000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 175000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 17000000.00
VEON income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -6000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 432000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Payables: 1595000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1595000000.00
VEON income_statement (quarterly, 2026-03-31) — Pretax Income: 183000000.00
VEON cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -165000000.00
VEON cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -32000000.00
VEON cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -232000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Receivables: 693000000.00
VEON income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 151000000.00
VEON income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 209000000.00
VEON cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -225000000.00
VEON cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -28000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -2899000000.00
VEON cash_flow (quarterly, 2026-03-31) — Sale Of Business: 60000000.00
VEON cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 34000000.00
VEON income_statement (quarterly, 2026-03-31) — Selling General And Administration: 533000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Share Issued: 1849190667.00
VEON income_statement (quarterly, 2026-03-31) — Special Income Charges: -2000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1468000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -426000000.00
VEON income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 4264000.00
VEON income_statement (quarterly, 2026-03-31) — Tax Provision: 60000000.00
VEON income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.33
VEON balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 44000000.00
VEON cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -65000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Total Assets: 9602000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1468000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Total Debt: 5423000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1863000000.00
VEON income_statement (quarterly, 2026-03-31) — Total Expenses: 893000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 7739000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 6482000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 4110000000.00
VEON income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 306000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 100000000.00
VEON income_statement (quarterly, 2026-03-31) — Total Unusual Items: 13000000.00
VEON income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 13000000.00
VEON balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 118156483.00
VEON balance_sheet (quarterly, 2026-03-31) — Working Capital: -509000000.00
VEON income_statement (quarterly, 2026-03-31) — Write Off: 2000000.00
VERA cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
VERA balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 867000.00
VERA income_statement (annual, 2021-12-31) — Basic Average Shares: 13435706.00
VERA income_statement (annual, 2021-12-31) — Basic EPS: -2.43
VERA cash_flow (annual, 2021-12-31) — Depreciation: 176000.00
VERA income_statement (annual, 2021-12-31) — Diluted Average Shares: 13435706.00
VERA income_statement (annual, 2021-12-31) — Diluted EPS: -2.43
VERA cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -2691000.00
VERA income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 2691000.00
VERA income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -892000.00
VERA balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 867000.00
VERA balance_sheet (annual, 2021-12-31) — Investments And Advances: 867000.00
VERA cash_flow (annual, 2021-12-31) — Long Term Debt Payments: 0.00
VERA cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: 796000.00
VERA cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -5000000.00
VERA cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 0.00
VERA balance_sheet (annual, 2021-12-31) — Non Current Accrued Expenses: 286000.00
VERA balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 51000.00
VERA cash_flow (annual, 2021-12-31) — Operating Gains Losses: -2691000.00
VERA balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 377000.00
VERA balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 1257000.00
VERA balance_sheet (annual, 2021-12-31) — Preferred Stock: 0.00
VERA cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 0.00
VERA cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
VERA income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
VERA cash_flow (annual, 2021-12-31) — Sale Of Intangibles: 796000.00
VERA cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
VERA income_statement (annual, 2021-12-31) — Special Income Charges: 2691000.00
VERA income_statement (annual, 2021-12-31) — Total Unusual Items: 1799000.00
VERA income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 1799000.00
VERA cash_flow (annual, 2021-12-31) — Unrealized Gain Loss On Investment Securities: 892000.00
VERA income_statement (annual, 2022-12-31) — +Operating Expense: 90903000.00
VERA income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
VERA balance_sheet (annual, 2022-12-31) — Accounts Payable: 11991000.00
VERA balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 290216000.00
VERA balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 58000.00
VERA income_statement (annual, 2022-12-31) — Basic Average Shares: 26570676.00
VERA income_statement (annual, 2022-12-31) — Basic EPS: -3.35
VERA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 79967000.00
VERA balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 5173000.00
VERA cash_flow (annual, 2022-12-31) — Capital Expenditure: -62000.00
VERA balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 6476000.00
VERA balance_sheet (annual, 2022-12-31) — Capital Stock: 28000.00
VERA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 43459000.00
VERA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 114653000.00
VERA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 101933000.00
VERA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -70552000.00
VERA cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -67596000.00
VERA cash_flow (annual, 2022-12-31) — Change In Account Payable: 10606000.00
VERA cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 7036000.00
VERA cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -111000.00
VERA cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -2602000.00
VERA cash_flow (annual, 2022-12-31) — Change In Payable: 10606000.00
VERA cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 17642000.00
VERA cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -8182000.00
VERA cash_flow (annual, 2022-12-31) — Change In Working Capital: 6747000.00
VERA cash_flow (annual, 2022-12-31) — Changes In Cash: -36215000.00
VERA balance_sheet (annual, 2022-12-31) — Common Stock: 28000.00
VERA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 76908000.00
VERA cash_flow (annual, 2022-12-31) — Common Stock Issuance: 86131000.00
VERA balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 8184000.00
VERA balance_sheet (annual, 2022-12-31) — Current Assets: 125698000.00
VERA balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 2645000.00
VERA balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 2645000.00
VERA balance_sheet (annual, 2022-12-31) — Current Liabilities: 25600000.00
VERA cash_flow (annual, 2022-12-31) — Depreciation: -846000.00
VERA cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: -846000.00
VERA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: -846000.00
VERA income_statement (annual, 2022-12-31) — Diluted Average Shares: 26570676.00
VERA income_statement (annual, 2022-12-31) — Diluted EPS: -3.35
VERA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -89056000.00
VERA balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 2780000.00
VERA income_statement (annual, 2022-12-31) — EBIT: -88063000.00
VERA income_statement (annual, 2022-12-31) — EBITDA: -88063000.00
VERA cash_flow (annual, 2022-12-31) — End Cash Position: 43752000.00
VERA cash_flow (annual, 2022-12-31) — Financing Cash Flow: 101933000.00
VERA cash_flow (annual, 2022-12-31) — Free Cash Flow: -67658000.00
VERA cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
VERA income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
VERA income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -809000.00
VERA balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -224000.00
VERA income_statement (annual, 2022-12-31) — General And Administrative Expense: 21910000.00
VERA balance_sheet (annual, 2022-12-31) — Gross PPE: 5224000.00
VERA income_statement (annual, 2022-12-31) — Interest Expense: 992000.00
VERA income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 992000.00
VERA income_statement (annual, 2022-12-31) — Interest Income: 1750000.00
VERA income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1750000.00
VERA cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 895000.00
VERA balance_sheet (annual, 2022-12-31) — Invested Capital: 101718000.00
VERA cash_flow (annual, 2022-12-31) — Investing Cash Flow: -70552000.00
VERA balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 58000.00
VERA balance_sheet (annual, 2022-12-31) — Investments And Advances: 58000.00
VERA cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 86131000.00
VERA cash_flow (annual, 2022-12-31) — Issuance Of Debt: 19816000.00
VERA balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 3831000.00
VERA balance_sheet (annual, 2022-12-31) — Long Term Debt: 24810000.00
VERA balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 28641000.00
VERA cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 19816000.00
VERA cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 86131000.00
VERA income_statement (annual, 2022-12-31) — Net Income: -89056000.00
VERA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -89056000.00
VERA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -89056000.00
VERA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -89056000.00
VERA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -89056000.00
VERA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -89056000.00
VERA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -89056000.00
VERA cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 0.00
VERA income_statement (annual, 2022-12-31) — Net Interest Income: 758000.00
VERA cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -70490000.00
VERA cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 19816000.00
VERA cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 19816000.00
VERA income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 758000.00
VERA cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -6097000.00
VERA balance_sheet (annual, 2022-12-31) — Net PPE: 5224000.00
VERA cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -62000.00
VERA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 76908000.00
VERA balance_sheet (annual, 2022-12-31) — Non Current Accrued Expenses: 286000.00
VERA income_statement (annual, 2022-12-31) — Normalized EBITDA: -87254000.00
VERA income_statement (annual, 2022-12-31) — Normalized Income: -88416890.00
VERA cash_flow (annual, 2022-12-31) — Operating Cash Flow: -67596000.00
VERA income_statement (annual, 2022-12-31) — Operating Income: -90903000.00
VERA income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
VERA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 27800861.00
VERA balance_sheet (annual, 2022-12-31) — Other Current Assets: 719000.00
VERA balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -224000.00
VERA income_statement (annual, 2022-12-31) — Other Gand A: 21910000.00
VERA income_statement (annual, 2022-12-31) — Other Income Expense: 1090000.00
VERA cash_flow (annual, 2022-12-31) — Other Non Cash Items: 5863000.00
VERA balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 513000.00
VERA income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 1899000.00
VERA balance_sheet (annual, 2022-12-31) — Other Properties: 51000.00
VERA balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 71194000.00
VERA balance_sheet (annual, 2022-12-31) — Payables: 14771000.00
VERA balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 22955000.00
VERA balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
VERA balance_sheet (annual, 2022-12-31) — Prepaid Assets: 10326000.00
VERA income_statement (annual, 2022-12-31) — Pretax Income: -89055000.00
VERA cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 2083000.00
VERA balance_sheet (annual, 2022-12-31) — Properties: 0.00
VERA cash_flow (annual, 2022-12-31) — Purchase Of Investment: -148490000.00
VERA cash_flow (annual, 2022-12-31) — Purchase Of PPE: -62000.00
VERA income_statement (annual, 2022-12-31) — Reconciled Depreciation: -846000.00
VERA income_statement (annual, 2022-12-31) — Research And Development: 68993000.00
VERA balance_sheet (annual, 2022-12-31) — Retained Earnings: -213112000.00
VERA cash_flow (annual, 2022-12-31) — Sale Of Intangibles: 0.00
VERA cash_flow (annual, 2022-12-31) — Sale Of Investment: 78000000.00
VERA income_statement (annual, 2022-12-31) — Selling General And Administration: 21910000.00
VERA balance_sheet (annual, 2022-12-31) — Share Issued: 27800861.00
VERA income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
VERA cash_flow (annual, 2022-12-31) — Stock Based Compensation: 8887000.00
VERA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 76908000.00
VERA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 76908000.00
VERA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -169890.00
VERA income_statement (annual, 2022-12-31) — Tax Provision: 1000.00
VERA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
VERA balance_sheet (annual, 2022-12-31) — Total Assets: 131435000.00
VERA balance_sheet (annual, 2022-12-31) — Total Capitalization: 101718000.00
VERA balance_sheet (annual, 2022-12-31) — Total Debt: 31286000.00
VERA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 76908000.00
VERA income_statement (annual, 2022-12-31) — Total Expenses: 90903000.00
VERA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 54527000.00
VERA balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 5737000.00
VERA balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 28927000.00
VERA income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -90903000.00
VERA income_statement (annual, 2022-12-31) — Total Unusual Items: -809000.00
VERA income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -809000.00
VERA cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 809000.00
VERA balance_sheet (annual, 2022-12-31) — Working Capital: 100098000.00
VERA income_statement (annual, 2023-12-31) — +Operating Expense: 102012000.00
VERA income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
VERA balance_sheet (annual, 2023-12-31) — Accounts Payable: 11118000.00
VERA balance_sheet (annual, 2023-12-31) — Accrued Interest Receivable: 512000.00
VERA balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 410492000.00
VERA cash_flow (annual, 2023-12-31) — Amortization Of Securities: -4433000.00
VERA income_statement (annual, 2023-12-31) — Basic Average Shares: 42707072.00
VERA income_statement (annual, 2023-12-31) — Basic EPS: -2.25
VERA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 43752000.00
VERA balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 2949000.00
VERA cash_flow (annual, 2023-12-31) — Capital Expenditure: -63000.00
VERA balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 3831000.00
VERA balance_sheet (annual, 2023-12-31) — Capital Stock: 44000.00
VERA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 45681000.00
VERA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 160716000.00
VERA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 133541000.00
VERA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -39431000.00
VERA cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -92181000.00
VERA cash_flow (annual, 2023-12-31) — Change In Account Payable: -873000.00
VERA cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -2215000.00
VERA cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -262000.00
VERA cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -2645000.00
VERA cash_flow (annual, 2023-12-31) — Change In Payable: -873000.00
VERA cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -3088000.00
VERA cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 173000.00
VERA cash_flow (annual, 2023-12-31) — Change In Working Capital: -5822000.00
VERA cash_flow (annual, 2023-12-31) — Changes In Cash: 1929000.00
VERA balance_sheet (annual, 2023-12-31) — Common Stock: 44000.00
VERA balance_sheet (annual, 2023-12-31) — Common Stock Equity: 101685000.00
VERA cash_flow (annual, 2023-12-31) — Common Stock Issuance: 115000000.00
VERA cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
VERA balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 6823000.00
VERA balance_sheet (annual, 2023-12-31) — Current Assets: 172023000.00
VERA balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 2436000.00
VERA balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 2436000.00
VERA balance_sheet (annual, 2023-12-31) — Current Liabilities: 22303000.00
VERA cash_flow (annual, 2023-12-31) — Depreciation: -4086000.00
VERA cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 21000.00
VERA cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 21000.00
VERA income_statement (annual, 2023-12-31) — Diluted Average Shares: 42707072.00
VERA income_statement (annual, 2023-12-31) — Diluted EPS: -2.25
VERA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -95990000.00
VERA balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 1926000.00
VERA income_statement (annual, 2023-12-31) — EBIT: -92203000.00
VERA income_statement (annual, 2023-12-31) — EBITDA: -92182000.00
VERA cash_flow (annual, 2023-12-31) — End Cash Position: 45681000.00
VERA cash_flow (annual, 2023-12-31) — Financing Cash Flow: 133541000.00
VERA cash_flow (annual, 2023-12-31) — Free Cash Flow: -92244000.00
VERA income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -47000.00
VERA balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 251000.00
VERA income_statement (annual, 2023-12-31) — General And Administrative Expense: 23787000.00
VERA balance_sheet (annual, 2023-12-31) — Gross PPE: 3041000.00
VERA income_statement (annual, 2023-12-31) — Interest Expense: 3786000.00
VERA income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 3786000.00
VERA income_statement (annual, 2023-12-31) — Interest Income: 7979000.00
VERA income_statement (annual, 2023-12-31) — Interest Income Non Operating: 7979000.00
VERA cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 3352000.00
VERA balance_sheet (annual, 2023-12-31) — Invested Capital: 151562000.00
VERA cash_flow (annual, 2023-12-31) — Investing Cash Flow: -39431000.00
VERA cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 115000000.00
VERA cash_flow (annual, 2023-12-31) — Issuance Of Debt: 24741000.00
VERA balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 1395000.00
VERA balance_sheet (annual, 2023-12-31) — Long Term Debt: 49877000.00
VERA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 51272000.00
VERA cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 24741000.00
VERA cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 115000000.00
VERA balance_sheet (annual, 2023-12-31) — Net Debt: 4196000.00
VERA income_statement (annual, 2023-12-31) — Net Income: -95990000.00
VERA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -95990000.00
VERA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -95990000.00
VERA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -95990000.00
VERA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -95990000.00
VERA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -95990000.00
VERA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -95990000.00
VERA income_statement (annual, 2023-12-31) — Net Interest Income: 4193000.00
VERA cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -39368000.00
VERA cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 24741000.00
VERA cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 24741000.00
VERA income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 4193000.00
VERA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -7256000.00
VERA balance_sheet (annual, 2023-12-31) — Net PPE: 3041000.00
VERA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -63000.00
VERA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 101685000.00
VERA balance_sheet (annual, 2023-12-31) — Non Current Accrued Expenses: 286000.00
VERA income_statement (annual, 2023-12-31) — Normalized EBITDA: -92182000.00
VERA income_statement (annual, 2023-12-31) — Normalized Income: -95990000.00
VERA cash_flow (annual, 2023-12-31) — Operating Cash Flow: -92181000.00
VERA income_statement (annual, 2023-12-31) — Operating Income: -102012000.00
VERA income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
VERA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 44452161.00
VERA balance_sheet (annual, 2023-12-31) — Other Current Assets: 2237000.00
VERA balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 251000.00
VERA income_statement (annual, 2023-12-31) — Other Gand A: 23787000.00
VERA income_statement (annual, 2023-12-31) — Other Income Expense: 1830000.00
VERA cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2550000.00
VERA balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 482000.00
VERA income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 1830000.00
VERA balance_sheet (annual, 2023-12-31) — Other Properties: 92000.00
VERA balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 115035000.00
VERA balance_sheet (annual, 2023-12-31) — Payables: 13044000.00
VERA balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 19867000.00
VERA balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
VERA balance_sheet (annual, 2023-12-31) — Prepaid Assets: 8558000.00
VERA income_statement (annual, 2023-12-31) — Pretax Income: -95989000.00
VERA cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1056000.00
VERA balance_sheet (annual, 2023-12-31) — Properties: 0.00
VERA cash_flow (annual, 2023-12-31) — Purchase Of Investment: -224930000.00
VERA cash_flow (annual, 2023-12-31) — Purchase Of PPE: -63000.00
VERA balance_sheet (annual, 2023-12-31) — Receivables: 512000.00
VERA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 21000.00
VERA cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
VERA income_statement (annual, 2023-12-31) — Research And Development: 78225000.00
VERA balance_sheet (annual, 2023-12-31) — Retained Earnings: -309102000.00
VERA cash_flow (annual, 2023-12-31) — Sale Of Investment: 185562000.00
VERA income_statement (annual, 2023-12-31) — Selling General And Administration: 23787000.00
VERA balance_sheet (annual, 2023-12-31) — Share Issued: 44452161.00
VERA cash_flow (annual, 2023-12-31) — Stock Based Compensation: 11493000.00
VERA balance_sheet (annual, 2023-12-31) — Stockholders Equity: 101685000.00
VERA balance_sheet (annual, 2023-12-31) — Tangible Book Value: 101685000.00
VERA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
VERA income_statement (annual, 2023-12-31) — Tax Provision: 1000.00
VERA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
VERA balance_sheet (annual, 2023-12-31) — Total Assets: 175546000.00
VERA balance_sheet (annual, 2023-12-31) — Total Capitalization: 151562000.00
VERA balance_sheet (annual, 2023-12-31) — Total Debt: 53708000.00
VERA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 101685000.00
VERA income_statement (annual, 2023-12-31) — Total Expenses: 102012000.00
VERA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 73861000.00
VERA balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 3523000.00
VERA balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 51558000.00
VERA income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -102012000.00
VERA income_statement (annual, 2023-12-31) — Total Unusual Items: -47000.00
VERA income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -47000.00
VERA cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 47000.00
VERA balance_sheet (annual, 2023-12-31) — Working Capital: 149720000.00
VERA income_statement (quarterly, 2024-09-30) — Basic Average Shares: 54898297.00
VERA income_statement (quarterly, 2024-09-30) — Basic EPS: -0.85
VERA income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 54898297.00
VERA income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.85
VERA balance_sheet (quarterly, 2024-09-30) — Dueto Related Parties Current: 105000.00
VERA balance_sheet (quarterly, 2024-09-30) — Net Debt: 23214000.00
VERA cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: 0.00
VERA balance_sheet (quarterly, 2024-09-30) — Non Current Accrued Expenses: 0.00
VERA balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 286000.00
VERA balance_sheet (quarterly, 2024-09-30) — Preferred Stock: 0.00
VERA income_statement (annual, 2024-12-31) — +Operating Expense: 167170000.00
VERA income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
VERA balance_sheet (annual, 2024-12-31) — Accounts Payable: 7665000.00
VERA balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 3773000.00
VERA balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1037948000.00
VERA cash_flow (annual, 2024-12-31) — Amortization Of Securities: -8972000.00
VERA income_statement (annual, 2024-12-31) — Basic Average Shares: 55326680.00
VERA income_statement (annual, 2024-12-31) — Basic EPS: -2.75
VERA cash_flow (annual, 2024-12-31) — Beginning Cash Position: 45681000.00
VERA balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 3372000.00
VERA balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 3372000.00
VERA cash_flow (annual, 2024-12-31) — Capital Expenditure: -972000.00
VERA balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 3951000.00
VERA balance_sheet (annual, 2024-12-31) — Capital Stock: 64000.00
VERA balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 92646000.00
VERA balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 640852000.00
VERA balance_sheet (annual, 2024-12-31) — Cash Equivalents: 89727000.00
VERA balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 89727000.00
VERA balance_sheet (annual, 2024-12-31) — Cash Financial: 2919000.00
VERA balance_sheet (quarterly, 2024-12-31) — Cash Financial: 2919000.00
VERA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 606673000.00
VERA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -425029000.00
VERA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -134679000.00
VERA cash_flow (annual, 2024-12-31) — Change In Account Payable: -3453000.00
VERA cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 7188000.00
VERA cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 351000.00
VERA cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -2407000.00
VERA cash_flow (annual, 2024-12-31) — Change In Payable: -3453000.00
VERA cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 3735000.00
VERA cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 981000.00
VERA cash_flow (annual, 2024-12-31) — Change In Working Capital: 2660000.00
VERA cash_flow (annual, 2024-12-31) — Changes In Cash: 46965000.00
VERA balance_sheet (annual, 2024-12-31) — Common Stock: 64000.00
VERA balance_sheet (annual, 2024-12-31) — Common Stock Equity: 577155000.00
VERA cash_flow (annual, 2024-12-31) — Common Stock Issuance: 632537000.00
VERA cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 345000000.00
VERA cash_flow (annual, 2024-12-31) — Common Stock Payments: -13000.00
VERA cash_flow (quarterly, 2024-12-31) — Common Stock Payments: 0.00
VERA balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 14253000.00
VERA balance_sheet (annual, 2024-12-31) — Current Assets: 651218000.00
VERA balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1483000.00
VERA balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 1483000.00
VERA balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1483000.00
VERA balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 1483000.00
VERA balance_sheet (annual, 2024-12-31) — Current Liabilities: 25371000.00
VERA cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 105000.00
VERA cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 105000.00
VERA income_statement (annual, 2024-12-31) — Diluted Average Shares: 55326680.00
VERA income_statement (annual, 2024-12-31) — Diluted EPS: -2.75
VERA income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -152148000.00
VERA balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 217000.00
VERA balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Current: 217000.00
VERA income_statement (annual, 2024-12-31) — EBIT: -144521000.00
VERA income_statement (annual, 2024-12-31) — EBITDA: -144416000.00
VERA cash_flow (annual, 2024-12-31) — End Cash Position: 92646000.00
VERA cash_flow (annual, 2024-12-31) — Financing Cash Flow: 606673000.00
VERA cash_flow (annual, 2024-12-31) — Free Cash Flow: -135651000.00
VERA balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 393000.00
VERA income_statement (annual, 2024-12-31) — General And Administrative Expense: 40998000.00
VERA balance_sheet (annual, 2024-12-31) — Gross PPE: 4332000.00
VERA balance_sheet (quarterly, 2024-12-31) — Gross PPE: 4332000.00
VERA income_statement (annual, 2024-12-31) — Interest Expense: 7626000.00
VERA income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 7626000.00
VERA income_statement (annual, 2024-12-31) — Interest Income: 20714000.00
VERA income_statement (annual, 2024-12-31) — Interest Income Non Operating: 20714000.00
VERA cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 6652000.00
VERA balance_sheet (annual, 2024-12-31) — Invested Capital: 627842000.00
VERA cash_flow (annual, 2024-12-31) — Investing Cash Flow: -425029000.00
VERA cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 632537000.00
VERA cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 345000000.00
VERA cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
VERA balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 2468000.00
VERA balance_sheet (annual, 2024-12-31) — Long Term Debt: 50687000.00
VERA balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 53155000.00
VERA cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
VERA cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 632524000.00
VERA cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 345000000.00
VERA income_statement (annual, 2024-12-31) — Net Income: -152148000.00
VERA income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -152148000.00
VERA income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -152148000.00
VERA income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -152148000.00
VERA income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -152148000.00
VERA cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -152148000.00
VERA income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -152148000.00
VERA income_statement (annual, 2024-12-31) — Net Interest Income: 13088000.00
VERA cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -424057000.00
VERA cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
VERA cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
VERA income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 13088000.00
VERA cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -39264000.00
VERA cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -21356000.00
VERA balance_sheet (annual, 2024-12-31) — Net PPE: 4332000.00
VERA balance_sheet (quarterly, 2024-12-31) — Net PPE: 4332000.00
VERA cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -972000.00
VERA balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 577155000.00
VERA balance_sheet (annual, 2024-12-31) — Non Current Accrued Expenses: 0.00
VERA balance_sheet (quarterly, 2024-12-31) — Non Current Accrued Expenses: 0.00
VERA income_statement (annual, 2024-12-31) — Normalized EBITDA: -144416000.00
VERA income_statement (annual, 2024-12-31) — Normalized Income: -152148000.00
VERA cash_flow (annual, 2024-12-31) — Operating Cash Flow: -134679000.00
VERA income_statement (annual, 2024-12-31) — Operating Income: -167170000.00
VERA income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
VERA balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 63559858.00
VERA balance_sheet (annual, 2024-12-31) — Other Current Assets: 1383000.00
VERA balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 1753000.00
VERA balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 1753000.00
VERA balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 393000.00
VERA income_statement (annual, 2024-12-31) — Other Gand A: 40998000.00
VERA income_statement (annual, 2024-12-31) — Other Income Expense: 1935000.00
VERA cash_flow (annual, 2024-12-31) — Other Non Cash Items: 2874000.00
VERA balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 131000.00
VERA income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 1935000.00
VERA balance_sheet (annual, 2024-12-31) — Other Properties: 960000.00
VERA balance_sheet (quarterly, 2024-12-31) — Other Properties: 960000.00
VERA balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 548206000.00
VERA balance_sheet (annual, 2024-12-31) — Payables: 7882000.00
VERA balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 22135000.00
VERA balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
VERA balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
VERA balance_sheet (annual, 2024-12-31) — Prepaid Assets: 5210000.00
VERA income_statement (annual, 2024-12-31) — Pretax Income: -152147000.00